COVID-19 Disease & Vaccine Survey in Africa

COVID-19 Disease & Vaccine Survey in Sub-Saharan Africa

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05950243

Enrollment

1000

Registered

2023-07-18

Start date

2021-01-02

Completion date

2023-12-31

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Vaccine Hesitancy

Keywords

COVID-19

Brief summary

The COVID-19 pandemic is a public health concern; for which the WHO recommends protective measures and vaccination. There is inadequate data on the impact of COVID-19 vaccination and control measures in Africa. This survey is collecting data about people's knowledge, attitude and compliance regarding COVID-19 disease and vaccines.

Detailed description

The coronavirus disease 2019 (COVID-19) pandemic remains a major public health concern. There is inadequate data on the epidemiology of COVID-19 in Africa. There are emerging COVID-19 variants with high transmissibility and morbidity. The World Health Organization (WHO) recommends protective measures and vaccination; for the control of COVID-19. There is inadequate data on the impact of COVID-19 vaccination and control measures in many nations in Africa. This study is a survey of specific urban populations in sub-Saharan Africa. The anonymized survey is collecting data about people's knowledge and attitude regarding COVID-19 disease or control measures. The survey is also collecting data about people's knowledge, attitude and compliance regarding COVID-19 vaccines. The study uses a validated questionnaire to collect data. The study aims to inform and improve COVID-19 management or control in Africa.

Interventions

BEHAVIORALQuestionnaire

Questionnaire survey for data collection

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

9 Years to 99 Years

Healthy volunteers

Yes

Inclusion criteria

* urban population in Africa * people in sub-Saharan Africa town

Exclusion criteria

* rural population * people outside sub-Saharan Africa

Design outcomes

Primary

Measure	Time frame	Description
Percentage of people who know about COVID-19 prevention	6 months	Percentage of people who know about COVID-19 preventive measures
Percentage of people who received COVID-19 vaccination	6 months	Percentage of people who received COVID-19 vaccination, 1st and 2nd doses

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026